Calcium And Vitamin D Reduce The Risk Of Skin Tumors.
Certain women at endanger for developing melanoma, the most aloof formula of skin cancer, may epitomize the likelihood in half by taking vitamin D with calcium supplements, a fresh study suggests vitomol.eu. "It looks like there is some propitious evidence for vitamin D and calcium for prevention of melanoma in a high-risk group," said foremost researcher Dr Jean Tang, an helpmeet professor of dermatology at Stanford University School of Medicine.
The women most at imperil of developing the life-threatening cancer are those who have had a preceding non-melanoma form of skin cancer, such as basal apartment or squamous cell cancer, the researchers said. Vitamin D and calcium are familiar for their roles in bone growth, but they also affect other cells in the body. Some studies have shown that vitamin D and calcium are associated with let chance of colon, breast, prostate and other cancers, the researchers said.
Tang speculated that cancer cells lurking in the flay of women who have had a early skin cancer may be waiting to develop into melanoma. "But if they exact calcium and vitamin D that reduces the gamble of developing an actual tumor". As little as 400 supranational units (IU) of vitamin D daily may be protective.
The US Institute of Medicine now recommends 600 IU of vitamin D daily. Calcium has also been shown to depreciate tumor crop in patients with colon cancer. "So c peradventure calcium has a role, too. I can't intend whether it was the calcium or the vitamin D that was important". But the cartel seemed to convey a benefit.
Whether these results would be seen in men or litter women isn't known. But an earlier scrutinize led by Tang found a benefit from vitamin D in reducing the jeopardize of melanoma among older men. "More studies stress to be done, because we want to make sure these results are geographically in other communities".
The report was published in the June 27 2011 online copy of the Journal of Clinical Oncology. For the study, Tang's side collected data on 36282 postmenopausal women, 50 to 79 years old, who took faction in the Women's Health Initiative study.
